Results 101 to 110 of about 3,249,142 (188)

Characterization of tricyclic anti-depressant drugs efficacy via topological indices. [PDF]

Sci Rep
Kour S, Sankar JR.
europepmc   +1 more source

The effects of vitamin B in depression [PDF]

, 2016
Apostolopoulos, Vasso, Mikkelsen, Kathleen, Stojanovska, Lily   +2 more
core   +1 more source

Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial.

Health Technol Assess
Kerr-Gaffney J, Zenasni Z, Goldsmith K, Yaziji N, Jin H, Colasanti A, Geddes J, Kessler D, McAllister-Williams RH, Young AH, Barrera A, Marwood L, Taylor RW, Tee H, Cleare AJ, LQD Study Group.   +15 more
europepmc   +1 more source

Utilizing depression symptom-based phenotypes to explore ketamine treatment response in major depression: The Bio-K multicenter trial. [PDF]

J Affect Disord
Penaluna BK, Vande Voort JL, Bobo WV, Pazdernik V, Achtyes ED, Goes FS, Greden JF, Parikh SV, Frye MA, Singh B.   +9 more
europepmc   +1 more source

Melatonin and melatonin agonists as antidepressants in the elderly: protocol for a systematic review and meta-analysis of randomised control trials. [PDF]

BMJ Open
Cardoso J, Pinto N, Maricoto T, Patto AV.   +3 more
europepmc   +1 more source

Inhaled sevoflurane use for myoclonic status secondary to bupropion intoxication. [PDF]

Crit Care Sci
Canasiro AR, Park M, Cardozo Junior LCM, Vilar GR, Hajjar LA.   +4 more
europepmc   +1 more source

Characteristics of Adults Age 18 and Older Who Took Prescription Medication for Depression: United States, 2023.

NCHS Data Brief
Elgaddal N, Weeks JD, Mykyta L.
europepmc   +1 more source

Activation of glutamine synthetase (GS) as a new strategy for the treatment of major depressive disorder and other GS-related diseases. [PDF]

Acta Pharmacol Sin
Kang JS, Kim H, Baek JH, Song M, Park H, Jeong W, Chung HJ, Yoo DY, Lee DK, Park SW, Kim HJ.   +10 more
europepmc   +1 more source

Identifying medication use clusters with the R package tame based on dose, timing and ATC codes. [PDF]

Sci Rep
Laksafoss A, Wohlfahrt J, Hviid A.
europepmc   +1 more source

[Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment]. [PDF]

Nervenarzt
Spangemacher M, Reinwald J, Adolphi H, Kärtner L, Mertens LJ, Schmitz CN, Gründer G.   +6 more
europepmc   +1 more source